CS
Publications
275
Views
135,392
Downloads
22,329
Supervised works
15
Items per page
1 - 275 of 275
Title Published in Access level OA Policy Year Views Downloads
Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North AmericaFrontiers in immunology
accessLevelPublic
2024 154 61
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonatesClinical infectious diseases
accessLevelPublic
2023 39 28
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents : 5-year durabilityClinical microbiology and infection
accessLevelRestricted
2023 80 0
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19Frontiers in immunology
accessLevelPublic
2023 153 21
Influence of circadian clocks on adaptive immunity and vaccination responsesNature communications
accessLevelPublic
2023 227 45
C-type lectin receptor agonists elicit functional IL21-expressing Tfh cells and induce primary B cell responses in neonatesFrontiers in immunology
accessLevelPublic
2023 52 23
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumabJAMA neurology
accessLevelPublic
2022 187 116
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 yearsScientific reports
accessLevelPublic
2022 89 14
Swiss recommendations on perioperative antimicrobial prophylaxis in childrenSwiss medical weekly
accessLevelPublic
2022 68 13
Transcriptomic signatures induced by the Ebola virus vaccine rVSV?G-ZEBOV-GP in adult cohorts in Europe, Africa, and North America : a molecular biomarker studyThe Lancet microbe
accessLevelPublic
2022 118 32
Long-term persistence of antibodies after diphtheria/tetanus vaccination in immunosuppressed patients with inflammatory rheumatic diseases and healthy controlsVaccine
accessLevelRestricted
2022 40 0
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence90th EAS (European Atherosclerosis Society) Congress
2022 62 0
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort StudyClinical infectious diseases
accessLevelPublic
2022 168 29
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistenceEuropean journal of clinical investigation
accessLevelPublic
2022 372 86
Replication-Deficient Lymphocytic Choriomeningitis Virus-Vectored Vaccine Candidate for the Induction of T Cell Immunity against Mycobacterium tuberculosisInternational journal of molecular sciences
accessLevelPublic
2022 215 81
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCsNature communications
accessLevelPublic
2022 227 118
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive AnalysisFrontiers in immunology
accessLevelPublic
2022 147 70
Is there a role for childhood vaccination against COVID-19?Pediatric allergy and immunology
accessLevelRestricted
2021 228 1
Human Transcriptomic Response to the VSV-Vectored Ebola VaccineVaccines
accessLevelPublic
2021 113 46
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1EAS Congress 2021
2021 272 38
Rabies vaccination and multiple sclerosis relapse: A retrospective cohort studyMultiple Sclerosis and Related Disorders
accessLevelPublic
2021 243 104
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunityCell reports
accessLevelPublic
2021 350 176
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infectionClinical Microbiology and Infection
accessLevelPublic
2021 476 269
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of SymptomsJournal of clinical immunology
accessLevelPublic
2021 244 88
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal studyClinical Microbiology and Infection
accessLevelPublic
2021 352 169
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1European Journal of Clinical Investigation
accessLevelPublic
2021 341 221
Risk of Vaccine-Preventable Infections in Swiss Adults with Inflammatory Bowel DiseaseDigestion
accessLevelPublic
2021 96 31
Faudra-t-il vacciner les enfants contre le Covid-19 ?Revue médicale suisse
accessLevelPublic
2021 58 27
Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipientsVaccine
accessLevelRestricted
2021 184 0
Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settingsJournal of Clinical Medicine
accessLevelPublic
2021 291 135
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationNPJ Vaccines
accessLevelPublic
2020 435 103
Validation of a commercially available SARS-CoV-2 serological immunoassayClinical Microbiology and Infection
accessLevelPublic
2020 454 237
Diagnostic accuracy of Augurix COVID-19 IgG serology rapid testEuropean Journal of Clinical Investigation
accessLevelPublic
2020 394 314
Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid testsJournal of Clinical Medicine
accessLevelPublic
2020 334 160
Risk of MS relapse after yellow fever vaccination: A self-controlled case seriesNeurology: Neuroimmunology & Neuroinflammation
accessLevelPublic
2020 194 59
A TLR7/8 Agonist-Including DOEPC-Based Cationic Liposome Formulation Mediates Its Adjuvanticity Through the Sustained Recruitment of Highly Activated Monocytes in a Type I IFN-Independent but NF-κB-Dependent MannerFrontiers in immunology
accessLevelPublic
2020 220 85
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trialClinical Microbiology and Infection
accessLevelPublic
2020 230 106
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case seriesmSphere
accessLevelPublic
2020 448 175
Missed vaccinations and critical care admission: all you may wish to know or rediscover-a narrative reviewIntensive Care Medicine
accessLevelRestricted
2020 456 0
High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel DiseaseAmerican Journal of Gastroenterology
accessLevelRestricted
2019 265 0
Long-term Seroprotection of Varicella-zoster Immunization in Pediatric Liver Transplant RecipientsTransplantation
accessLevelRestricted
2019 387 1
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centersCell Reports
accessLevelPublic
2019 260 151
Detectable Vesicular Stomatitis Virus (VSV)-specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humansThe Journal of Infectious Diseases
accessLevelPublic
2019 192 124
Safety and immunogenicity of tetanus/diphtheria vaccination in patients with rheumatic diseases-a prospective multi-centre cohort studyRheumatology
accessLevelRestricted
2019 276 0
Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidatesAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
accessLevelRestricted
2019 387 3
Neonatal T follicular helper cells are lodged in a pre-T follicular helper stage favoring innate over adaptive germinal center responsesFrontiers in Immunology
accessLevelPublic
2019 286 138
Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantationAmerican Journal of Transplantation
accessLevelRestricted
2019 465 4
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical TrialClinical Infectious Diseases
accessLevelPublic
2019 259 268
Site-specific DC surface signatures influence CD4+ T cell co-stimulation and lung-homingFrontiers in Immunology
accessLevelPublic
2019 260 145
Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including FormulationFrontiers in Immunology
accessLevelPublic
2019 237 119
Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland's largest pre-trial prisonJournal of Global Health
accessLevelPublic
2018 377 180
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlanFrontiers in Immunology
accessLevelPublic
2018 445 400
Prévention de la grippe en milieu de soins aigus : une intervention multimodaleRevue médicale suisse
accessLevelPublic
2018 431 147
Correlates of vaccine-induced protective immunity against Ebola virus diseaseSeminars in Immunology
accessLevelPublic
2018 579 214
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccinationNPJ Vaccines
accessLevelPublic
2018 379 137
Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein 180L Single-Nucleotide Polymorphism Is Associated With Susceptibility to Recurrent Pneumococcal Lower Respiratory Tract Infections in ChildrenFrontiers in Immunology
accessLevelPublic
2018 483 200
Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort studyThe Lancet Infectious Diseases
accessLevelRestricted
2018 463 0
Durability of single-dose rVSV-ZEBOV vaccine responses: what do we know?Expert Review of Vaccines
accessLevelPrivate
2018 329 0
A dose-dependent plasma signature of the safety and immunogenicity of the rVSV-Ebola vaccine in Europe and AfricaScience Translational Medicine
accessLevelRestricted
2017 577 2
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal ImmunizationClinical Infectious Diseases
accessLevelPublic
2017 585 226
Volunteer feedback and perceptions after participation in a phase I, first-in-human Ebola vaccine trial: An anonymous surveyPLOS ONE
accessLevelPublic
2017 465 181
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementationThe Journal of Maternal - Fetal & Neonatal Medicine
accessLevelRestricted
2017 429 0
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussisClinical infectious diseases
accessLevelRestricted
2016 689 5
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhoodProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
2016 604 2
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe : Preliminary ReportThe New England journal of medicine
accessLevelPublic
2016 854 241
Reply to Abu Raya et alClinical infectious diseases
accessLevelRestricted
2016 405 3
Vaccination in early life: standing up to the challengesCurrent Opinion in Immunology
accessLevelRestricted
2016 463 1
IL-36-Induced Toxicity in Neonatal Mice Involves TNF-α Production by Liver Myeloid CellsJournal of Immunology
accessLevelRestricted
2016 504 2
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genesThe Journal of experimental medicine
accessLevelRestricted
2016 710 4
The 2014–2015 Ebola outbreak in West Africa: Hands OnAntimicrobial Resistance and Infection Control
accessLevelPublic
2016 487 219
Optimizing seroprotection against pneumococcus in children with nephrotic syndrome using the 13-valent pneumococcal conjugate vaccineVaccine
accessLevelRestricted
2016 545 3
Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: A single blind, partially randomized Phase I studyVaccine
accessLevelRestricted
2015 486 0
The Nucleoprotein Is Required for Lymphocytic Choriomeningitis Virus-Based Vaccine Vector ImmunogenicityJournal of virology
accessLevelRestricted
2015 548 2
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialLancet. Infectious diseases
accessLevelRestricted
2015 655 0
Vaccination recommendations for adult patients with autoimmune inflammatory rheumatic diseasesSchweizerische medizinische Wochenschrift
accessLevelRestricted
2015 576 1
Protective efficacy of individual CD8+ T cell specificities in chronic viral infectionThe Journal of immunology
accessLevelRestricted
2015 591 0
Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case reportLancet. Infectious diseases
accessLevelRestricted
2015 648 1
Ebola vaccine R&D: Filling the knowledge gapsScience translational medicine
accessLevelRestricted
2015 472 1
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeThe Journal of immunology
accessLevelRestricted
2015 596 2
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of conceptVaccine
accessLevelPublic
2015 589 134
Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted InfectionPLOS pathogens
accessLevelPublic
2015 651 278
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal studyArthritis research & therapy
accessLevelPublic
2015 508 443
Bordetella holmesii: an under-recognised Bordetella speciesLancet. Infectious diseases
accessLevelRestricted
2014 607 0
Diagnosis of whooping cough in Switzerland: differentiating Bordetella pertussis from Bordetella holmesii by polymerase chain reactionPloS one
accessLevelPublic
2014 703 299
Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young childrenEuropean journal of clinical microbiology & infectious diseases
accessLevelPublic
2013 648 261
Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in childrenThe Pediatric infectious disease journal
accessLevelRestricted
2013 578 0
Memory B cell compartment constitution and susceptibility to recurrent lower respiratory tract infections in young childrenJournal of leukocyte biology
accessLevelRestricted
2013 729 0
Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newbornThe Pediatric infectious disease journal
accessLevelRestricted
2013 688 3
Tetanus immunity as a surrogate for past diphtheria-tetanus-pertussis immunization in migrant childrenThe Pediatric infectious disease journal
accessLevelRestricted
2013 650 5
Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early lifePloS one
accessLevelPublic
2013 678 374
Calendrier vaccinal InfoVac pratique 2013Archives de pédiatrie
accessLevelRestricted
2013 617 6
Homing and adhesion patterns determine the cellular composition of the bone marrow plasma cell nicheThe Journal of immunology
accessLevelRestricted
2012 570 0
Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccineAntiviral therapy
accessLevelRestricted
2012 611 6
Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*HIV medicine
accessLevelRestricted
2012 578 1
Use of pneumococcal polysaccharide vaccine in children: what is the evidence?Current opinion in infectious diseases
accessLevelRestricted
2012 520 0
Determinants of hepatitis A vaccine immunity in a cohort of human immunodeficiency virus-infected children living in SwitzerlandClinical and vaccine immunology
accessLevelRestricted
2012 633 0
Comparison of clinical presentation of respiratory tract infections in H1N1/09-positive and H1N1/09-negative patientsEuropean journal of pediatrics
accessLevelPublic
2012 664 243
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 526 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 543 0
Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccinePloS one
accessLevelPublic
2012 723 309
Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemiaClinical microbiology and infection
accessLevelRestricted
2012 556 0
Varicella-zoster immunization in pediatric liver transplant recipients: safe and immunogenicAmerican journal of transplantation
accessLevelRestricted
2012 737 1
Acceptability of maternal immunization against influenza: the critical role of obstetriciansJournal of maternal-fetal & neonatal medicine
accessLevelRestricted
2012 682 0
Vaccination against seasonal flu in Switzerland: The indecision of pregnant women encouraged by healthcare professionalsRevue d'épidémiologie et de santé publique
accessLevelRestricted
2012 671 3
Environmental and T cell-intrinsic factors limit the expansion of neonatal follicular T helper cells but may be circumvented by specific adjuvantsThe Journal of immunology
accessLevelRestricted
2012 572 0
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patientsHIV medicine
accessLevelRestricted
2012 675 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2012 549 0
Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference centerPediatric transplantation
accessLevelRestricted
2012 646 0
A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analogJournal of controlled release
accessLevelRestricted
2012 619 1
A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatientsThe oncologist
accessLevelRestricted
2012 637 0
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responsesThe Journal of immunology
accessLevelRestricted
2012 623 0
Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac diseaseJournal of pediatric gastroenterology and nutrition
accessLevelPublic
2012 597 412
Vaccinologie : nouvelles recommandations pour les rappels tétanos, diphtérie et coqueluche chez l'adulteRevue médicale suisse
accessLevelRestricted
2012 560 2
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination programPharmacoepidemiology and drug safety
accessLevelRestricted
2012 579 1
Bulletin spécial calendrier vaccinalArchives de pédiatrie
accessLevelRestricted
2011 484 2
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2011 529 0
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsHaematologica
accessLevelPublic
2011 987 571
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticlesBioconjugate chemistry
accessLevelPrivate
2011 616 0
Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised childrenVaccine
accessLevelRestricted
2011 599 0
Challenges in infant immunity: implications for responses to infection and vaccinesNature immunology
accessLevelRestricted
2011 445 0
Vaccination during pregnancy to protect infants against influenza: why and why not?Vaccine
accessLevelRestricted
2011 574 0
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyArthritis and rheumatism
accessLevelRestricted
2011 833 8
Bulletin spécial semaine de la vaccination: rougeole avril no 4/2011 1Archives de pédiatrie
accessLevelRestricted
2011 390 0
De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipientsAmerican journal of transplantation
accessLevelRestricted
2011 622 0
ABCB1 polymorphisms and neuropsychiatric adverse events in oseltamivir-treated children during influenza H1N1/09 pandemiaPharmacogenomics
accessLevelRestricted
2011 917 6
Neonatal immunization: where do we stand?Current opinion in infectious diseases
accessLevelRestricted
2011 491 2
Encephalitis associated with glutamic acid decarboxylase autoantibodies in a child: a treatable condition?Archives of neurology
accessLevelRestricted
2011 640 0
Bulletin InfoVac-FranceArchives de pédiatrie
accessLevelRestricted
2011 517 0
The next decade of vaccines: societal and scientific challengesLancet
accessLevelRestricted
2011 623 0
Immunity to pneumococcal surface proteins in children with community-acquired pneumonia: a distinct pattern of responses to pneumococcal choline-binding protein AClinical microbiology and infection
accessLevelRestricted
2011 602 0
Bulletin infovacArchives de pédiatrie
accessLevelRestricted
2011 490 0
Improvement of measles immunity among migrant populations: lessons learned from a prevalence study in a Swiss prisonSchweizerische medizinische Wochenschrift
accessLevelRestricted
2011 707 1
Vaccine effectiveness in older individuals: what has been learned from the influenza-vaccine experienceAgeing research reviews
accessLevelPublic
2011 628 1,028
Actualités vaccinologiques suisses: nouveaux vaccins glycoconjugués contre pneumocoques et méningocoquesRevue médicale suisse
accessLevelRestricted
2011 449 1
Mode of action of adjuvants: implications for vaccine safety and designBiologicals
accessLevelRestricted
2010 589 0
Vaccinologie. Questions autour de la sécurité des vaccins adjuvantes contre la grippe A(H1N1)Revue médicale suisse
accessLevelRestricted
2010 485 1
Glycoconjugate vaccines and immune interference: A reviewVaccine
accessLevelRestricted
2010 507 0
Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunityNature medicine
accessLevelRestricted
2010 533 0
Frequent failure of adolescent booster responses to tetanus toxoid despite infant immunization: waning of infancy-induced immune memory?Vaccine
accessLevelRestricted
2010 539 0
Chickenpox in a Swiss prison: susceptibility, post-exposure vaccination and control measuresScandinavian journal of infectious diseases
accessLevelRestricted
2010 681 3
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancyThe Journal of infectious diseases
accessLevelRestricted
2010 507 0
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected childrenArchives of disease in childhood
accessLevelRestricted
2010 644 0
Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countriesMedicine
accessLevelRestricted
2010 563 1
Booster vaccination after neonatal priming with acellular pertussis vaccineThe Journal of pediatrics
accessLevelRestricted
2010 548 0
B-cell responses to vaccination at the extremes of ageNature reviews. Immunology
accessLevelRestricted
2009 557 0
Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trialsLancet
accessLevelRestricted
2009 629 0
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccinesLancet
accessLevelRestricted
2009 532 0
Impaired antibody response causes persistence of prototypic T cell-contained virusPLoS biology
accessLevelPublic
2009 682 679
Comment on "Dendritic cells and monocyte/macrophages that create the IL-6/APRIL-rich lymph node microenvironment where plasmablasts mature"The Journal of immunology
accessLevelRestricted
2009 496 0
Vaccinologie : quel rattrapage pour les patients avec des vaccinations inconnues ou incomplètes ?Revue médicale suisse
accessLevelRestricted
2009 471 0
Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theoriesVaccine
accessLevelRestricted
2009 630 0
Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelinesEuropean journal of pediatrics
accessLevelRestricted
2009 635 0
Immunization and transplantation--what is new and what is coming?Pediatric transplantation
accessLevelRestricted
2009 476 0
A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cellsPloS one
accessLevelPublic
2009 652 381
Allergies et vaccins : distinguer le vrai du fauxRevue médicale suisse
accessLevelRestricted
2009 459 0
Determinants of vaccine immunity in the cohort of human immunodeficiency virus-infected children living in SwitzerlandThe Pediatric infectious disease journal
accessLevelRestricted
2009 598 0
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablastsBlood
accessLevelRestricted
2008 660 0
Recurrence of cardiorespiratory events following repeat DTaP-based combined immunization in very low birth weight premature infantsThe Journal of pediatrics
accessLevelRestricted
2008 559 0
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster responseThe Journal of immunology
accessLevelRestricted
2008 570 2
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected childrenThe Pediatric infectious disease journal
accessLevelRestricted
2008 617 3
Rougeole : diagnostic et prise en charge d'une maladie toujours d'actualitéRevue médicale suisse
accessLevelRestricted
2008 598 0
Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibodyClinical infectious diseases
accessLevelRestricted
2008 525 0
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cellsBlood
accessLevelRestricted
2008 632 0
Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunizationThe Journal of pediatrics
accessLevelRestricted
2008 543 1
Actualités vaccinologiques pour 2008: quoi de neuf en Suisse ?Revue médicale suisse
accessLevelRestricted
2008 450 0
Protective anti-mycobacterial T cell responses through exquisite in vivo activation of vaccine-targeted dendritic cellsEuropean Journal of Immunology
accessLevelRestricted
2008 557 0
Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniaeVaccine
accessLevelRestricted
2008 609 1
Adult-like anti-mycobacterial T cell and in vivo dendritic cell responses following neonatal immunization with Ag85B-ESAT-6 in the IC31 adjuvantPloS one
accessLevelPublic
2008 619 372
Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infantsThe Journal of pediatrics
accessLevelRestricted
2008 571 0
Autoimmune diseases after adolescent or adult immunization: what should we expect?CMAJ. Canadian Medical Association journal
accessLevelPublic
2007 501 237
Mechanisms underlying adverse reactions to vaccinesJournal of comparative pathology
accessLevelRestricted
2007 540 0
Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference centerPediatric transplantation
accessLevelRestricted
2007 590 0
Proximal splenic artery embolization for blunt splenic injury: clinical, immunologic, and ultrasound-Doppler follow-upThe Journal of trauma
accessLevelRestricted
2007 492 0
Workshop on vaccine pressure and Neisseria meningitidis, Annecy, France, 9-11 March 2005Vaccine
accessLevelRestricted
2007 444 0
Atorvastatin treatment and vaccination efficacyJournal of clinical pharmacology
accessLevelRestricted
2007 575 0
Influence of anesthesia on immune responses and its effect on vaccination in children: review of evidencePaediatric anaesthesia
accessLevelRestricted
2007 598 2
Author's reply [Vaccination and anesthesia]Paediatric anaesthesia
accessLevelRestricted
2007 517 0
Vaccination des patients souffrant de maladies chroniques du foieRevue médicale suisse
accessLevelRestricted
2007 466 2
The challenges of vaccine responses in early life: selected examplesJournal of comparative pathology
accessLevelRestricted
2007 530 0
Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ effector T cells and absence of memory CD8+ T cellsJournal of virology
accessLevelPublic
2007 526 368
Vaccinologie : Plan de vaccination suisse 2007 : première lectureRevue médicale suisse
accessLevelRestricted
2007 460 4
Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactionsThe Pediatric infectious disease journal
accessLevelRestricted
2007 485 0
Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?Clinical and vaccine immunology
accessLevelPublic
2006 688 454
Actualités vaccinologiques 2005 : nouvelle catégorie de recommandations pour une protection vaccinale optimaleRevue médicale suisse
accessLevelRestricted
2006 464 0
Enhanced chickenpox exanthema in vaccine injection siteScandinavian journal of infectious diseases
accessLevelRestricted
2006 467 0
Influence of genetic and environmental factors on the immunogenicity of Hib vaccine in Gambian twinsVaccine
accessLevelRestricted
2006 506 0
Early life T cell responses to pneumococcal conjugates increase with age and determine the polysaccharide-specific antibody response and protective efficacyEuropean Journal of Immunology
accessLevelRestricted
2006 489 0
Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survivalThe Journal of immunology
accessLevelPublic
2006 568 305
Les vaccins sous haute surveillance : effets indésirables des vaccins : questions posée et réponses apportées par InfoVacArchives de pédiatrie
accessLevelRestricted
2006 468 1
B. Zinka et al., Unexplained cases of sudden infant death shortly after hexavalent vaccinationVaccine
accessLevelRestricted
2006 587 0
Effect of month of vaccine administration on antibody responses in The Gambia and PakistanTM & IH. Tropical medicine and international health
accessLevelRestricted
2006 516 0
Predominant influence of environmental determinants on the persistence and avidity maturation of antibody responses to vaccines in infantsThe Journal of infectious diseases
accessLevelPublic
2006 538 343
Immunisation of premature infantsArchives of disease in childhood
accessLevelRestricted
2006 460 0
VaccinologieRevue médicale suisse
accessLevelRestricted
2005 412 0
Die Folgen einer ungenügenden Herdimmunität bei «pädiatrischen» Infektionskrankheiten - Beispiel einer MasernepidemieTherapeutische Umschau
accessLevelRestricted
2005 627 0
How do physicians immunize their own children? Differences among pediatricians and nonpediatriciansPediatrics
accessLevelRestricted
2005 487 0
Can successful vaccines teach us how to induce efficient protective immune responses?Nature medicine
accessLevelRestricted
2005 537 0
Infections récurrentes des voies respiratoires inférieures de l'enfant : quand et comment les investiguer ?Revue médicale suisse
accessLevelRestricted
2005 535 0
Vaccine safety controversies and the future of vaccination programsThe Pediatric infectious disease journal
accessLevelRestricted
2005 597 0
La vaccinologie, une science neuve aux prises avec les croyancesRevue médicale suisse
accessLevelRestricted
2005 416 0
Les adjuvants vaccinaux et la myofasciite à macrophagesArchives de pédiatrie
accessLevelRestricted
2005 544 1
The immunomodulating properties of human respiratory syncytial virus and immunostimulating complexes containing Quillaja saponin components QH-A, QH-C and ISCOPREP703FEMS immunology and medical microbiology
accessLevelPublic
2005 538 252
The advantage of mucosal immunization for polysaccharide-specific memory responses in early lifeEuropean Journal of Immunology
accessLevelRestricted
2005 406 0
Immunisation, immunomodulation et prévention des infections respiratoiresRevue médicale suisse
accessLevelRestricted
2005 452 0
A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine SafetyAmerican journal of public health
accessLevelPublic
2004 534 596
Aluminum hydroxide adjuvant induces macrophage differentiation towards a specialized antigen-presenting cell typeVaccine
accessLevelRestricted
2004 615 0
Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responsesVaccine
accessLevelRestricted
2004 543 0
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine responseVaccine
accessLevelRestricted
2004 591 0
Safety of DTaP-based combined immunization in very-low-birth-weight premature infants: frequent but mostly benign cardiorespiratory eventsThe Journal of pediatrics
accessLevelRestricted
2004 494 0
Genetic regulation of immune responses to vaccines in early lifeGenes and immunity
accessLevelRestricted
2004 495 0
Safety and efficacy of immune-stimulating complex-based antigen delivery systems for neonatal immunisation against respiratory syncytial virus infectionMicrobes and infection
accessLevelRestricted
2004 504 0
Partial activation of neonatal CD11c+ dendritic cells and induction of adult-like CD8+ cytotoxic T cell responses by synthetic microspheresThe Journal of immunology
accessLevelPublic
2004 595 663
Hepatitis B immunisation induces higher antibody and memory Th2 responses in new-borns than in adultsVaccine
accessLevelRestricted
2004 525 0
Inhibition of B cell death causes the development of an IgA nephropathy in (New Zealand white x C57BL/6)F(1)-bcl-2 transgenic miceThe Journal of immunology
accessLevelRestricted
2004 566 0
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeysThe American journal of tropical medicine and hygiene
accessLevelPublic
2004 920 1,055
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinantsVaccine
accessLevelRestricted
2003 421 0
Seroprevalence of Bordetella pertussis antibodies in Flanders (Belgium)Vaccine
accessLevelRestricted
2003 523 0
CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal miceVaccine
accessLevelRestricted
2003 588 0
CD4-independent protective cytotoxic T cells induced in early life by a non-replicative delivery system based on virus-like particlesVirology
accessLevelPublic
2003 567 321
Les adjuvants vaccinaux et la myofasciite à macrophagesBulletin de l'Académie nationale de médecine
accessLevelRestricted
2003 536 0
Enhanced pulmonary immunopathology following neonatal priming with formalin-inactivated respiratory syncytial virus but not with the BBG2NA vaccine candidateVaccine
accessLevelRestricted
2003 544 0
Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implicationsThe Journal of experimental medicine
accessLevelPublic
2003 479 858
Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigensThe Journal of immunology
accessLevelPublic
2003 497 441
Successful induction of CD8 T cell-dependent protection against malaria by sequential immunization with DNA and recombinant poxvirus of neonatal mice born to immune mothersThe Journal of immunology
accessLevelPublic
2003 541 513
Prévention vaccinale chez les adolescents : et s'il suffisait d'y penser ?Médecine et hygiène
accessLevelRestricted
2003 409 2
Efficient in vivo priming of specific cytotoxic T cell responses by neonatal dendritic cellsThe Journal of immunology
accessLevelPublic
2002 534 259
Polémiques de sécurité vaccinale : fin d'une histoire ou histoire sans fin ?Médecine et hygiène
accessLevelRestricted
2002 355 0
Generation of adult-like antibody avidity profiles after early-life immunization with protein vaccinesEuropean Journal of Immunology
accessLevelRestricted
2002 513 2
Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal miceInfection and immunity
accessLevelPublic
2002 483 254
Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussisInfection and immunity
accessLevelPublic
2002 544 252
Response to treatment and disease progression linked to CD4+ T cell surface CC chemokine receptor 5 density in human immunodeficiency virus type 1 vertical infectionThe Journal of infectious diseases
accessLevelRestricted
2002 544 0
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccinationThe Journal of immunology
accessLevelPublic
2002 529 302
Epidemiology of herpes simplex virus in children by detection of specific antibodies in salivaThe Pediatric infectious disease journal
accessLevelRestricted
2001 521 0
Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vectorVirology
accessLevelPublic
2001 558 290
Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodiesFEMS immunology and medical microbiology
accessLevelPublic
2001 501 252
Neonatal and early life vaccinologyVaccine
accessLevelRestricted
2001 551 0
Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early lifeEuropean Journal of Immunology
accessLevelRestricted
2001 455 2
The search for novel adjuvants for early life vaccinations: can "danger" motifs show us the way?Archivum Immunologiae et Therapiae Experimentalis
accessLevelRestricted
2001 415 0
Adjuvant effects of CpG oligodeoxynucleotides on responses against T-independent type 2 antigensImmunology
accessLevelPublic
2001 567 493
Infections récidivantes de l'enfant : quel dépistage immunitaire ?Archives de pédiatrie
accessLevelRestricted
2001 450 0
Nosocomial outbreak of multiple bloodborne viral infectionsThe Journal of infectious diseases
accessLevelPublic
2001 571 226
How to improve communication on vaccine issues at the national level? INFOVAC-PED: an example from SwitzerlandVaccine
accessLevelRestricted
2001 493 0
Detection of enteroviruses in the cerebrospinal fluid by polymerase chain reaction: prospective study of impact on the management of hospitalized childrenClinical pediatrics
accessLevelRestricted
2000 534 0
Expression of MHC class II molecules contributes to lipopolysaccharide responsivenessEuropean Journal of Immunology
accessLevelRestricted
2000 437 0
Vaccin contre la fièvre jaune : formellement contre-indiqué chez les transplantésMédecine et hygiène
accessLevelRestricted
2000 424 0
A brief view of known landmarks reorientates path integration in hamstersNaturwissenschaften
accessLevelRestricted
2000 567 0
Non, le vaccin contre l'hépatite B ne provoque pas la sclérose en plaques : retour sur un psychodrame collectifLa Recherche
accessLevelRestricted
2000 525 1
Quand et comment vacciner les prématurés ?Médecine et hygiène
accessLevelRestricted
2000 359 0
Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in miceEuropean Journal of Immunology
accessLevelRestricted
1999 491 0
Antigen-Presentation Systems, Immunomodulators, and Immune Responses to VaccinesHandbook of experimental pharmacology
accessLevelRestricted
1999 354 0
Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussisLancet
accessLevelRestricted
1999 487 0
CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal primingThe Journal of immunology
accessLevelPublic
1999 464 178
Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study GroupAIDS
accessLevelRestricted
1998 428 0
Determinants of infant responses to vaccines in presence of maternal antibodiesVaccine
accessLevelRestricted
1998 451 0
Die Impfung gegen Hepatitis BSozial- und Präventivmedizin
accessLevelRestricted
1998 445 0
Quel avenir pour les vaccins ?Revue médicale de la Suisse romande
accessLevelRestricted
1998 428 0
Procalcitonin is a marker of severity of renal lesions in pyelonephritisPediatrics
accessLevelRestricted
1998 538 1
Hépatite B et sclérose en plaques : comment répondre aux inquiétudes du public ?Médecine et hygiène
accessLevelRestricted
1998 419 0
Influenza immunization: improving compliance of healthcare workersInfection control and hospital epidemiology
accessLevelRestricted
1998 493 0
Immunity in early lifeImmunology today
accessLevelRestricted
1998 463 0
New challenges for global immunizationSymposium in Immunology: Vol. VII : Vaccination
accessLevelRestricted
1998 450 0
Immunity in early life : an introduction [Proceedings of the International Symposium on Immunity in Early Life. Annecy, France, 17-19 November 1997]Vaccine
accessLevelRestricted
1998 452 0
Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells?Vaccine
accessLevelRestricted
1998 516 0
Influence of maternal antibodies on vaccine responses: inhibition of antibody but not T cell responses allows successful early prime-boost strategies in miceEuropean Journal of Immunology
accessLevelRestricted
1998 529 0
Vaccination des sujets présentant un problème médical : précautions, contre-indicationsRevue médicale de la Suisse romande
accessLevelRestricted
1998 456 0
Optimization of vaccine responses in early life: the role of delivery systems and immunomodulatorsImmunology and cell biology
accessLevelPublic
1998 456 471
Maternal immunity and infant responses to immunization : actors influencing infant responsesPreclinical and clinical development of new vaccines : proceedings of a symposium, Institut Pasteur, Paris, France, 27-28 May 1997
accessLevelRestricted
1998 377 0
Les vaccins contre l'hépatite BSozial- und Präventivmedizin
accessLevelRestricted
1998 501 0
Le développement de nouveaux vaccins à usage pédiatrique : progrès et défisRevue médicale de la Suisse romande
accessLevelRestricted
1998 440 0
CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young miceProceedings of the National Academy of Sciences of the United States of America
accessLevelPublic
1998 529 675
Cervical lymphadenitis caused by Mycobacterium genavense in a healthy childThe Pediatric infectious disease journal
1996 605 0
Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promotersThe Journal of biological chemistry
accessLevelRestricted
1994 581 0
Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-YProceedings of the National Academy of Sciences of the United States of America
accessLevelRestricted
1994 568 0
RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancerMolecular and cellular biology
accessLevelRestricted
1993 567 0
Septicémie à anaérobes après infections oropharyngées (septicémie post-angine de Lemierre): un syndrome oubliéSchweizerische medizinische Wochenschrift
1983 718 0
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack